3D BioFibR raises new capital to scale up manufacturing

prelim 70 mid 10x A Fine v1Biomaterial manufacturing company 3D BioFibR has announced it has raised more than US$700,000 in an oversubscribed follow-on round.

Proceeds from the financing will be used to continue to scale-up the Halifax, Nova Scotia, Canada-based company’s manufacturing capabilities of collagen and spider silk fibres with the aim of securing commercial partnerships.

For the full story, see the October 2021 edition of Medical Textiles.


Image: 3D BioFibR